The UofL Health Heart Valve Team is a multidisciplinary team of cardiovascular specialists dedicated to delivering advanced treatments for heart valve disease. The team consists of interventional cardiologists, cardiovascular surgeons, cardiologists, anesthesiologists and a program coordinator. The team works together to determinethe best treatment for each patient.
When it comes to your heart, UofL Heart and Vascular Care is the clear choice.
Transcatheter Aortic Valve Replacement (TAVR) is a procedure for select patients with severe symptomatic aortic stenosis (narrowing of the aortic valve opening) who are not candidates for traditional open chest surgery or are high-risk operable candidates.
Unlinke surgery, the MitraClip procedure does not require opening the chest and temporarily stopping the heart. Instead, doctors access the mitral valve with a thin tube (called a catheter) that is guided through a vein in your leg to reach your heart. The MitraClip device is a small clip that is attached to your mitral valve and treats mitral regurgitationa by allowing your mitral valve to close more complelty, helping to restore normal blood flow through your heart.
On July 17, 2009, Robert Bolli, M.D. led a study team of leaders in the field of cardiovascular and stem cell medicine that used an infusion of "C-kit positive" adult cardiac stem cells to treat heart disease - the world's first phase-one FDA-approved clinical trial. During the infusion procedure, the patient, 66-year old Michael Jones, was directly injected with his own cardiac stem cells into heart scar tissue using a minimmally-invasive cardiac catheterization procedure.